Dare announces availability of telehealth consultations for DARE to PLAY

Dare Bioscience (DARE) announced the availability of telehealth consultations for DARE to PLAY Sildenafil Cream, a proprietary topical arousal cream designed specifically for women to enhance genital blood flow and arousal response. This marks the first time women nationwide can begin the process of obtaining a prescription for a clinically studied, topical sildenafil cream designed specifically for female sexual arousal. “Many women experience sexual health concerns but have not yet connected with a healthcare provider about them,” said Sabrina Johnson, President and Chief Executive Officer of Dare Bioscience. “Telehealth access through the DARE Health Hub provides a convenient opportunity to connect with knowledgeable healthcare providers without an in-person visit or needing to schedule an appointment. We are pleased that women can now take proactive steps to access DARE to PLAY in all 50 continental states in the U.S.. We believe DARE to PLAY(TM) represents a long overdue correction, giving women an option to reconnect with their own bodies, their pleasure, and their confidence, using science that finally recognizes their needs.”